Abstract
This paper covers European medicines control, including the role played by individual Member States. The different contributions of each of the constituent players will be put into perspective by reflecting on the principles of the process rather than on details of the procedures. The new system in Europe, based on single market legislation, is covered.
Get full access to this article
View all access options for this article.